Adicet Bio, Inc.
ACET
$0.6387
-$0.0323-4.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 176.30M | 202.07M | 224.07M | 247.59M | 159.71M |
| Total Receivables | -- | 210.00K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.83M | 4.04M | 4.28M | 2.76M | 2.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 180.14M | 206.32M | 228.35M | 250.35M | 162.27M |
|
|
|||||
| Total Current Assets | 180.14M | 206.32M | 228.35M | 250.35M | 162.27M |
| Net Property, Plant & Equipment | 36.75M | 39.14M | 39.90M | 42.05M | 44.20M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.33M | 508.00K | 593.00K | 691.00K | 822.00K |
| Total Assets | 220.22M | 245.96M | 268.84M | 293.10M | 207.30M |
|
|
|||||
| Total Accounts Payable | 4.83M | 2.50M | 1.90M | 2.54M | 2.63M |
| Total Accrued Expenses | 11.43M | 13.62M | 12.58M | 11.60M | 13.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.13M | 3.28M | 3.42M | 3.32M | 3.22M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 19.39M | 19.39M | 17.90M | 17.46M | 19.29M |
|
|
|||||
| Total Current Liabilities | 19.39M | 19.39M | 17.90M | 17.46M | 19.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.10M | 14.92M | 15.71M | 16.71M | 17.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 116.00K | 116.00K | 116.00K | 116.00K | 130.00K |
| Total Liabilities | 33.61M | 34.43M | 33.73M | 34.29M | 37.12M |
|
|
|||||
| Common Stock & APIC | 684.49M | 680.58M | 673.80M | 667.59M | 550.95M |
| Retained Earnings | -497.89M | -469.17M | -438.69M | -408.79M | -380.77M |
| Treasury Stock & Other | 16.00K | 121.00K | -- | -- | -- |
| Total Common Equity | 186.61M | 211.53M | 235.11M | 258.80M | 170.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 186.61M | 211.53M | 235.11M | 258.80M | 170.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 186.61M | 211.53M | 235.11M | 258.80M | 170.18M |
|
|
|||||
